Clinical Trial Update: Real World Evidence Study of SYN023 in Children Exposed to Rabies

View source ↗

Summary

Real-world evidence study of SYN023 in children exposed to rabies is currently recruiting, aiming to evaluate the product in pediatric post-exposure scenarios.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• SYN023 (SYN023)

Snippet

Sponsor: Synermore Biologics (Suzhou) Co., Ltd. | Conditions: Rabies Post-exposure Prophylaxis | Status: RECRUITING